SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Monday, March 8, 2010

REVERSED

1600 Biotechnology and Organic Chemistry
Ex Parte Srivastava et al LEBOVITZ 102(b)/103(a) RICHARD ARON OSMAN

2800 Semiconductors, Electrical and Optical Systems and Components
Ex Parte Ku et al BOALICK 102(e)/103(a) HARNESS, DICKEY & PIERCE, P.L.C.

Inherency may not be established by probabilities or possibilities, and “[t]he mere fact that a certain thing may result from a given set of circumstances is not sufficient.” Continental Can Co. v. Monsanto Co., 948 F.2d 1264, 1268 (Fed. Cir. 1991).

Continental Can Co. v. Monsanto Co., 948 F.2d 1264, 20 USPQ2d 1746 (Fed. Cir. 1991).. . . . . . . . . . . . . . . . . . . . . 2131.01

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
Ex Parte Doerwald et al FETTING 101/103(a) BERESKIN AND PARR LLP/S.E.N.C.R.L., s.r.l.

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
Ex Parte Coffey2 WALSH 112(1)/103(a) FULBRIGHT & JAWORSKI L.L.P.

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
Ex Parte Madsen McCARTHY 103(a) MORRISS OBRYANT COMPAGNI, P.C.

Ex Parte Simpson et al FETTING 103(a) HEWLETT-PACKARD COMPANY

Nonobviousness cannot be established by attacking the references individually when the rejection is predicated upon a combination of prior art disclosures. See In re Merck & Co. Inc., 800 F.2d 1091, 1097 (Fed. Cir. 1986).

Merck & Co., Inc., In re, 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986) . . . . . . . .707.07(f), 716.02, 2143.02, 2144.08, 2144.09, 2145

3700 Mechanical Engineering, Manufacturing, and Products & Design
Ex Parte Coffey WALSH 112(1)/103(a) FULBRIGHT & JAWORSKI L.L.P.


No comments :